Drug recall · January 12, 2022
GoodSense Aller.Ease recall
Why: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GoodSense Aller.Ease, Fexofenadine hydrochloride 12 HR, 60 mg tablets, 24 count bottle, UPC 3 0113 0425 62 7; Made in the Czech Republic, Distributed by: Perrigo Allergan MI 49010.
- Lots / codes
Lot# 0JE2487 , 0KE2982, Exp 1/31/2022
- Quantity
- 36,048 containers
- Company
- Perrigo Company PLC, Allegan, MI
- Distribution
- Nationwide in the USA
- Initiated
- July 27, 2021 · Voluntary: Firm initiated
- Classified
- January 5, 2022
- Reported
- January 12, 2022
- Ended
- November 8, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.